Lv51
850 积分 2025-01-22 加入
De Ritis ratio and long-term major cardiovascular adverse events in patients undergoing elective percutaneous coronary intervention
6小时前
待确认
Early versus later anticoagulation for stroke with atrial fibrillation
3个月前
已完结
Optimal Timing of Anticoagulation After Acute Ischaemic Stroke with atrial fibrillation (OPTIMAS): a multicentre, blinded-endpoint, phase 4, randomised controlled trial
3个月前
已完结
Early vs Late Anticoagulation in Minor, Moderate, and Major Ischemic Stroke With Atrial Fibrillation: Post Hoc Analysis of the ELAN Randomized Clinical Trial
3个月前
已完结
Early Versus Late Initiation of Direct Oral Anticoagulants After Ischemic Stroke in People With Atrial Fibrillation and Hemorrhagic Transformation: Prespecified Subanalysis of the Randomized Controlled ELAN Trial
3个月前
已完结
Rivaroxaban and aspirin vs. aspirin alone in Asian compared with non-Asian patients with chronic coronary artery disease or peripheral arterial disease: the COMPASS trial
3个月前
已完结
Rivaroxaban Plus Aspirin Versus Aspirin Alone After Endovascular Revascularization for Symptomatic PAD: Insights From VOYAGER PAD
3个月前
已完结
Aspirin Plus Rivaroxaban Versus Rivaroxaban Alone for the Prevention of Venous Stent Thrombosis Among Patients With Post-Thrombotic Syndrome: The Multicenter, Multinational, Randomized, Open-Label ARIVA Trial
3个月前
已完结
The Pharmacology, Efficacy, and Safety of Rivaroxaban in Renally Impaired Patient Populations
3个月前
已完结
Plasma Rivaroxaban Level in Patients With Early Stages of Chronic Kidney Disease-Relationships With Renal Function and Clinical Events. Plasma Rivaroxaban Level in Patients With Early Stages of Chronic Kidney Disease-Relationships With Renal Function and Clinical Events
3个月前
已完结
皖公网安备34019202002308
